MacroGenics (MGNX)

• Market cap: $74.4M
• 1 day: -6.35%
• 5 days: -7.09%
• 1 month: -45.87%
• 3 months: -61.06%
• 6 months: -71.36%
• Year to date: -64.24%
• 1 year: -92.93%
• 5 years: -77.31%
• 10 years: -96.49%
• Sector: Healthcare
• Industry: Biotechnology

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

21% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 19

14% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 36

2% more funds holding

Funds holding: 123 [Q3] → 126 (+3) [Q4]

0.26% more ownership

Funds ownership: 88.93% [Q3] → 89.19% (+0.26%) [Q4]

3% less capital invested

Capital invested by funds: $188M [Q3] → $182M (-$5.77M) [Q4]

73% less call options, than puts

Call options by funds: $174K | Put options by funds: $644K

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $2 69% upside
• Avg. target: $2 69% upside
• High target: $2 69% upside

1 analyst rating

• positive: 0 0%
• neutral: 1 100%
• negative: 0 0%

HC Wainwright & Co. Robert Burns 16% 1-year accuracy 28 / 173 met price target

69% upside $2

Neutral Maintained

25 Mar 2025